List of Novo Nordisk patents

Patents where

Current Assignee

Name

Novo Nordisk

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10485920 Needle unit with a lockable needle shield and an injection device comprising such a needle unit	Patent 10485920 was granted and assigned to Novo Nordisk on November, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10485920	November 26, 2019
‌ US Patent 10005827 Double-acylated GLP-1 derivatives	Patent 10005827 was granted and assigned to Novo Nordisk on June, 2018 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10005827	June 26, 2018
‌ US Patent 10335464 Device for titrating basal insulin	Patent 10335464 was granted and assigned to Novo Nordisk on July, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10335464	July 2, 2019
‌ US Patent 7500959 Medication delivery system with improved dose accuracy	Patent 7500959 was granted and assigned to Novo Nordisk on March, 2009 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7500959	March 10, 2009
‌ US Patent 8361036 Injection device having a gearing arrangement	Patent 8361036 was granted and assigned to Novo Nordisk on January, 2013 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8361036	January 29, 2013
‌ US Patent 8298172 Medical skin mountable device and system	Patent 8298172 was granted and assigned to Novo Nordisk on October, 2012 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8298172	October 30, 2012
‌ US Patent 7922096 Support for a cartridge for transferring an electronically readable item of information from the cartridge to an electronic circuit	Patent 7922096 was granted and assigned to Novo Nordisk on April, 2011 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7922096	April 12, 2011
‌ US Patent 9527900 Double-acylated GLP-1 derivatives	Patent 9527900 was granted and assigned to Novo Nordisk on December, 2016 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	9527900	December 27, 2016
‌ US Patent 9266940 Double-acylated GLP-1 derivatives	Patent 9266940 was granted and assigned to Novo Nordisk on February, 2016 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	9266940	February 23, 2016
‌ US Patent 8221356 Medication delivery system with a detector for providing a signal indicative of an amount of a set and/or ejected dose of drug	Patent 8221356 was granted and assigned to Novo Nordisk on July, 2012 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8221356	July 17, 2012
‌ US Patent 8395581 User interface for medical system comprising diary function with time change feature	Patent 8395581 was granted and assigned to Novo Nordisk on March, 2013 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8395581	March 12, 2013
‌ US Patent RE41956 Dose setting limiter	Patent RE41956 was granted and assigned to Novo Nordisk on November, 2010 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	RE41956	November 23, 2010
‌ US Patent 7133329 Device with time indicating means	Patent 7133329 was granted and assigned to Novo Nordisk on November, 2006 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7133329	November 7, 2006
‌ US Patent 9649448 Rotary sensor module with resynchronization feature	Patent 9649448 was granted and assigned to Novo Nordisk on May, 2017 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	9649448	May 16, 2017
‌ US Patent 10105497 Drug delivery device with integrated magnetic movement indicator	Patent 10105497 was granted and assigned to Novo Nordisk on October, 2018 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10105497	October 23, 2018
‌ US Patent 7955297 Retraction means for transcutaneous device	Patent 7955297 was granted and assigned to Novo Nordisk on June, 2011 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7955297	June 7, 2011
‌ US Patent 10117999 Medical injection system with dose capturing	Patent 10117999 was granted and assigned to Novo Nordisk on November, 2018 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10117999	November 6, 2018
‌ US Patent 9675761 Drug delivery device with variable dose setting mechanism	Patent 9675761 was granted and assigned to Novo Nordisk on June, 2017 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	9675761	June 13, 2017
‌ US Patent 10213554 Accessory device with mounting safety feature	Patent 10213554 was granted and assigned to Novo Nordisk on February, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10213554	February 26, 2019
‌ US Patent 10016134 Portable device and method of communicating medical data information	Patent 10016134 was granted and assigned to Novo Nordisk on July, 2018 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	10016134	July 10, 2018
‌ US Patent 7628770 Pivotable needle unit	Patent 7628770 was granted and assigned to Novo Nordisk on December, 2009 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7628770	December 8, 2009
‌ US Patent 8062253 Medical skin mountable device	Patent 8062253 was granted and assigned to Novo Nordisk on November, 2011 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8062253	November 22, 2011
‌ US Patent 10406291 Autoinjector having needle shield triggering	Patent 10406291 was granted and assigned to Novo Nordisk on September, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10406291	September 10, 2019
‌ US Patent 9415104 Combination therapy to enhance NK cell mediated cytotoxicity	Patent 9415104 was granted and assigned to Novo Nordisk on August, 2016 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	9415104	August 16, 2016
‌ US Patent 10155090 System for determining position of an element in relation to another element using magnetic fields	Patent 10155090 was granted and assigned to Novo Nordisk on December, 2018 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10155090	December 18, 2018

...

Results per page:

650 results

0 selected

650 results

0 selected